In today’s recent session, 2.5 million shares of the Edwards Lifesciences Corp (NYSE:EW) have been traded, and its beta is 1.11. Most recently the company’s share price was $76.85, and it changed around $0.63 or 0.82% from the last close, which brings the market valuation of the company to $45.08B. EW at last check was trading at a discount to its 52-week high of $95.25, offering almost -23.94% off that amount. The share price’s 52-week low was $58.93, which indicates that the recent value has risen by an impressive 23.32% since then. We note from Edwards Lifesciences Corp’s average daily trading volume that its 10-day average is 4.96 million shares, with the 3-month average coming to 4.83 million.
Edwards Lifesciences Corp stock received a consensus recommendation rating of Hold, based on a mean score of 2.16. If we narrow it down even further, the data shows that 1 out of 33 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 17 recommended EW as a Hold, whereas 10 deemed it a Buy, and 0 rated it as Underweight.
Edwards Lifesciences Corp (NYSE:EW) trade information
Instantly EW has been showing a green trend so far today with a performance of 0.82% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 78.67 on recent trading dayincreased the stock’s daily price by 2.31%. The company’s shares are currently up 3.80% year-to-date, but still down -1.27% over the last five days. On the other hand, Edwards Lifesciences Corp (NYSE:EW) is 1.73% up in the 30-day period. We can see from the shorts that 7.38 million shares have been sold at a short interest cover period of 1.58 day(s).
The consensus price target as assigned by Wall Street analysts is $76.5, which translates to bulls needing to decrease their stock price by -0.46% from its current value. Analyst projections state that EW is forecast to be at a low of $74 and a high of $90.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -2.36%. Edwards Lifesciences Corp earnings are expected to increase by 1.63% in 2025, but the outlook is positive 8.55% per year for the next five years.
EW Dividends
Edwards Lifesciences Corp’s next quarterly earnings report is expected to be released on 2025-Apr-22.
Edwards Lifesciences Corp (NYSE:EW)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.92% of Edwards Lifesciences Corp shares, and 89.68% of them are in the hands of institutional investors. The stock currently has a share float of 90.51%. Edwards Lifesciences Corp stock is held by 1768.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 8.8982% of the shares, which is about 53.58 million shares worth $4.95 billion.
BLACKROCK INC., with 8.4663% or 50.98 million shares worth $4.71 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 18.49 shares worth $1.43 billion, making up 3.15% of all outstanding shares. On the other hand, VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund held roughly 18.39 shares worth around $1.42 billion, which represents about 3.14% of the total shares outstanding.
